Navigation Links
BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
Date:7/7/2008

PLYMOUTH MEETING, Pa., July 7 /Xinhua-PRNewswire/ -- BMP Sunstone Corporation (Nasdaq: BJGP; ''BMP Sunstone'' or the ''Company'') today announced that it received the New Business License for BMP Sunstone's establishment of an enterprise with foreign investment in the People's Republic of China, from the Shanghai Administration for Industry and Commerce (SHAIC). With receipt of this license, the Company has completed the acquisition of 63.3 percent of Shanghai Rongheng Pharmaceutical Co., Ltd. (''Rongheng''). Shanghai Rongheng International Trade Co., Ltd. of Orient International (Holding) Co., CAS Shanghai Shenglongda Biotech Group and one other individual own the remainder of Rongheng.

David Gao, Chief Executive Officer of BMP Sunstone stated, "We are very pleased to complete the Rongheng acquisition, which is one more important step in our corporate mission to control direct access to the high end pharmaceutical markets in Beijing, Shanghai and the Guangdong province. These areas are China's top pharmaceutical markets and generate roughly 60 percent of all high-end pharmaceutical imports into the country. Through this acquisition, BMP Sunstone will gain direct coverage of 80 percent of the top-tier hospitals and 40 percent of the retail pharmacies in Shanghai, which enable us to penetrate the market more effectively and increase our market share in this important city.''

Rongheng is a pharmaceutical distribution company which distributes over 400 pharmaceutical products to more than 140 top-tier hospitals and 1,000 retail pharmacies in Shanghai. Rongheng was founded in 1999 by CAS Shanghai Shenglongda Biotech Group, a high-tech biomedical group focused on research and development, marketing and sales of new biotechnology and pharmaceuticals in China, and Orient International (Holding) Co., one of the largest foreign trade enterprises in China.

Mr. Gao continued, ''We believe that today's achievement is in the best interest of our custo
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BMP Sunstone Announces Official Launch of Ferriprox in PRC
2. BMP Sunstone Announces Participation in June Investor Conferences
3. BMP Sunstone Reports First Quarter 2008 Financial Results
4. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
5. BMP Sunstone Announces Participation in May Investor Conferences
6. BMP Sunstone to Report First Quarter 2008 Financial Results
7. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
8. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
9. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
10. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
11. Beeston completes drilling on Bluff Lake property, 100 Mile House
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... cardiovascular disease , , THURSDAY, Ja...the millions of American men and women with type 2...the day may be symptoms of obstructive sleep apnea... one out of three diabetics. , Based on strong ...obal health experts are encouraging physicians to ...
(Date:1/8/2009)...ta receives $20,000 to support local programs as p... , MINNEAPOLIS, Minn., Jan. 8 /PRNewswire-USNews...eived $20,000 in funding to support Project UNIFY ...tional program. Project UNIFY is an initiative to ...an effort to promote school communities where all ...
(Date:1/8/2009)...e the U.S. Food and Drug Administration Drug has q... complex nature of diseases for which new therapeu...inical development times, according to the Tufts C...verage time for the FDA to approve new drugs decli... average clinical phase time means combined clinic...
(Date:1/8/2009)...8 Warner Chilcott Limite...resent at the 27th Annual JP Morgan Conference on ...ting for Warner Chilcott will be Roger Boissonneau... Herendeen, Executive Vice President and Chief Fin...ion will be webcast live for all interested partie...
Breaking Medicine News(10 mins):Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 2Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 3Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2
...ts why the commonly prescribed cholesterol-lowerin...h, reported by scientists at Wake Forest Universi... the Journal of Clinical Investigation and will ap...had previously been thought that the drug works by...
...ntified common DNA variations that underlie suscep... of the eight genetic alterations the scientists i... smallpox vaccination. A few, however, reduced fev...possibility the same genetic variations linked to ...
...al conference of the European Society of Human Gen...n undergo chromosomal modifications. Ms Tsvia F...spital, Tel Aviv Sourasky Medical Centre, Tel Aviv...hat her teams findings meant that the results of p...
...arch studies focused primarily on men and the resu...n. But we now know that the biological sex and gen...an skin deep. Beginning in 1990, the Society for W...advocacy organization, conveyed to a national audi...
Other Medicine News:Health News:Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Preimplanted Genetic Screening Should Be Interpreted With Caution 2Health News:Rare Womens Lung Disease May Yield Insights Into Common Diseases 2
(Date:1/8/2009).... 8 If you are taking prescription... alone. Half of the people taking,prescription me...e,varied -- they forget, are busy with other prio...ompliance has been called the Achilles heel of mod... Koop commented, "Drugs don,t,work in people who ...
(Date:1/8/2009)... at the initial dose in an ongoing Phase Ib trial ... after three days , , Conference Call Today at ...irstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq:...ohort of an ongoing Phase Ib clinical trial of ANA...polymerase inhibitor. ANA598 was very well-tolera...
(Date:1/7/2009)...Jan. 7 Scientists have ... likelihood of relapse in children with acute lymp... caution that further research is needed to determ...AROS, lead to leukemia relapse, the findings are ...tests to assess the risk of treatment failure. By ...
(Date:1/7/2009)...Jan. 7 ImQuest Life Sciences annou...lication to the Food and Drug Administration to in...dinedione HIV inhibitor IQP-0410. ImQuest anticipa...quarter of 2009. IQP-0410 is a novel small molecul...cleoside reverse transcriptase inhibitor (NNRTI). ...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Trial Date Set for Victim Hit by Ambulance 14985 1Trial Date Set for Victim Hit by Ambulance 14985 2Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 1Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 2Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 3FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 1FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 2FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 3St Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 1585 1St Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 1585 2
...Md., April 25, 2007-The U.S. Food and Drug,Adminis...ree of,Permanent Injunction against PharmaFab Inc....ls, Mark Tengler, PharmaFab,s president,and Russ ...rs, to,stop the illegal manufacture and distributi...cts. The products are illegal because,they are not...
...ralia 24 April 2007. Giaconda Ltd (ASX: GIA) today...n (FDA) has,approved the Company,s Investigational...opment of MyocondaR to treat patients with,Crohn,s...atuberculosis (MAP). , ,The Company understands th...py to be submitted to the FDA for this indication....
Other Medicine Technology:Major Manufacturer of Unapproved and Adulterated Drugs 2Major Manufacturer of Unapproved and Adulterated Drugs 3FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4
... in providing versatile liquid handling platforms ...livers even more flexibility and possibilities for...er with the new easy-to-use software, Freedom EVOw...te genomics, proteomics, and drug discovery applic...
...om DePuy offers a comprehensive combination of com...ecommendations regarding occupational exposure to ...rd for comfort. , ,The PROVISION System is de...htweight, hose-free, bicycle helmet design. , ,...
...rpness and efficiency with an innovative and compr...asty. Advanced trephine blade technology provides...ritical fit needed for successful transplants. Th...tem enables surgeons to select the style and size ...
Misys Laboratory is a comprehensive, high-performance, information system that manages specimen data from requisition entry through specimen tracking to final cumulative report production. Misys Labo
Medicine Products: